Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Equity (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Return on Equity for 14 consecutive years, with 0.11% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 19.0% year-over-year to 0.11%, compared with a TTM value of 0.11% through Dec 2025, up 19.0%, and an annual FY2025 reading of 0.12%, up 20.0% over the prior year.
  • Return on Equity was 0.11% for Q4 2025 at Amicus Therapeutics, down from 0.06% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.06% in Q3 2025 and bottomed at 1.85% in Q4 2022.
  • Average Return on Equity over 5 years is 0.95%, with a median of 0.97% recorded in 2021.
  • The sharpest move saw Return on Equity plummeted -112bps in 2022, then skyrocketed 86bps in 2025.
  • Year by year, Return on Equity stood at 0.73% in 2021, then tumbled by -153bps to 1.85% in 2022, then skyrocketed by 44bps to 1.03% in 2023, then soared by 71bps to 0.3% in 2024, then skyrocketed by 64bps to 0.11% in 2025.
  • Business Quant data shows Return on Equity for FOLD at 0.11% in Q4 2025, 0.06% in Q3 2025, and 0.19% in Q2 2025.